Skip to main content
. 2022 Mar 3;51:102269. doi: 10.1016/j.redox.2022.102269

Fig. 1.

Fig. 1

LMH001 specificity and efficacy as p47phoxinhibitor. a. LMH001 structure. b. Kd and Ki values of LMH001 tested by fluorescence polarization. mP: millipolarization units. c-d. HPLC-MS/MS detection of LMH001 in COS-p22/p47phox cells with or without PMA stimulation. c. LMH001 detected in p47phox immunoprecipitation (IP) pellets. d. LMH001 detected in the fractions left after p47phox IP. Mup47: p47phox S303-4/379A mutation. Results were expressed as fold changes of Cos-p22phox cells transfected with an empty vector (Vec) (values = 1). e-h. Lucigenin-chemiluminescence. e. O2.- production by xanthine plus xanthine oxidase (X + XO) or PMA-stimulated COS-phox cells. f. O2.- production by mouse peripheral blood mononuclear cells (PBMC). g-h. Oxidative burst response of PBMC isolated from mice after 14 d ip injection of LMH001. MLU: mean light units. *P < 0.05 for indicated values versus vehicle control values. n = 6 independent cell cultures or isolations.